Clinical Trial Update: Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating stereotactic MR-guided adaptive radiotherapy for locally advanced pancreatic adenocarcinoma; current status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Locally Advanced Pancreatic Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING